Systematic Review On Ischemic Events And PostMyocardial Infarction Heart Failure: From Initial Approach To Definitive Treatment
Journal of Cardiovascular Diseases · 2025
DOI: 10.52338/jocd.2025.5134 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Cardiovascular Diseases, 2025. Verfasst von Camila Tomasi und 25 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Acute myocardial infarction (AMI) remains one of the leading causes of global morbidity and mortality, despite advances in diagnostic and treatment strategies.Among its complications, post-ischemic heart failure (HF) stands out as a clinical outcome with a major impact, responsible for a significant increase in hospitalizations, reduced quality of life, and elevated mortality rates in the medium and long term.Understanding the pathophysiological evolution from AMI to HF is essential, as it involves factors such as the extent of myocardial necrosis, adverse ventricular remodeling, neurohormonal activation, and persistent inflammatory processes.The literature shows that the initial approach to AMI, especially early reperfusion by percutaneous coronary intervention or thrombolysis, reduces immediate mortality but does not eliminate the risk of developing HF.Studies such as those by O'Gara et al. (2013) and Ibanez et al. (2018) show a significant prevalence of HF even in scenarios with optimized reperfusion, suggesting that mechanisms other than coronary obstruction contribute to functional deterioration.In the context of chronic treatment, combined pharmacological therapies-including beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, aldosterone antagonists, and, more recently, sacubitril/valsartan-have been shown to reduce mortality and hospitalizations, as evidenced in multicenter studies such as those by McMurray et al. (2014) and Velazquez et al. (2016).In addition, international guidelines, such as those proposed by Ponikowski et al. (2016) and Heidenreich et al. (2022), reinforce the importance of risk stratification, multidisciplinary management, and continuous outpatient followup to prevent the progression of HF.Despite these achievements, significant challenges remain, especially in countries with unequal access to healthcare.Rates of post-infarction HF remain high, and the heterogeneity of outcomes across different populations reflects gaps in the universal application of evidence-based therapies.In addition, adverse ventricular remodeling remains a central process, reinforcing the need for preventive strategies and individualized therapies.This systematic review integrates the main findings in the literature on the relationship between AMI, subsequent ischemic events, and post-infarction HF, covering everything from the initial approach to definitive treatment.The results point to an evolutionary line of care, initially focused on reperfusion, later consolidated with combined pharmacotherapy, and more recently expanded to innovative and personalized therapies.It is concluded that post-ischemic HF should be understood not only as an inevitable complication but as an outcome that can be prevented, mitigated, and effectively treated, provided that guidelines are followed, access to therapies is expanded, and new technologies are incorporatedinto clinical care.
Zitieren
APA
Tomasi, C., Junior, J. E. B., Araújo, L. F. D., Neto, O. M. F., Malaquias, D. T. M., Oliveira, M. B. D. S., Saraiva, G. L., Martins, G. G., Souza, M. E. K. M. D., Lauretto, L., Vão, É. M. F. M., Silva, J. C. F. D., Tabera, F. A. P. V., Tobias, V. G., Dias, A. L. V., Zane, I. D. M., Rosa, L. B., Marques, E. M., Tutela, R. R., …, & Mendonça, C. H. B. F. D. (2025). Systematic Review On Ischemic Events And PostMyocardial Infarction Heart Failure: From Initial Approach To Definitive Treatment. Journal of Cardiovascular Diseases. https://doi.org/10.52338/jocd.2025.5134
Vancouver
Tomasi C, Junior JEB, Araújo LFD, Neto OMF, Malaquias DTM, Oliveira MBDS, et al. Systematic Review On Ischemic Events And PostMyocardial Infarction Heart Failure: From Initial Approach To Definitive Treatment. Journal of Cardiovascular Diseases. 2025. doi:10.52338/jocd.2025.5134
BibTeX
@article{Tomasi2025,
author = {Tomasi, Camila and Junior, Joel Eloi Belo and Araújo, Leocadia Felix de and Neto, Orseli Marques Ferreira and Malaquias, Délio Tiago Martins and Oliveira, Marilda Bispo de Sá and Saraiva, Gabriel Leonardo and Martins, Guilherme Guissone and Souza, Maria Eduarda Kartabil Machado de and Lauretto, Larissa and Vão, Érica Miriam Fernandes Miranda and Silva, José Carlos Ferreira da and Tabera, Felix Adriano Pietroluongo Vidal and Tobias, Victoria Geovana and Dias, Andre Luiz Vergamini and Zane, Ingrid de Mariz and Rosa, Letícia Brustolim and Marques, Enzo Maruzzo and Tutela, Rubens Rodrigues and Ribeiro, Ana Clara Lobo and Neto, José Antônio do Nascimento and Mota, Francisco Rogério de Sousa and Vilarinho, Cindy Alves and Diegues, Giancarlo Damasceno and Bezerra, Thiago Augusto Rochetti and Mendonça, Carlos Henrique Batista Figueiredo de},
title = {Systematic Review On Ischemic Events And PostMyocardial Infarction Heart Failure: From Initial Approach To Definitive Treatment},
journal = {Journal of Cardiovascular Diseases},
year = {2025},
doi = {10.52338/jocd.2025.5134}
}
EUVIMED